Transparency of cooperation
Each year we publish a report covering our cooperation with healthcare professionals and healthcare organisations, including the fees and other financial benefits that they have received.
Disclosure is carried out in accordance with the instructions of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and its member organisation Pharma Industry Finland. For its part, Biocodex Nordics wants to ensure transparency and openness of the cooperation. Cooperation between healthcare professionals and pharmaceuticals industry is essential for developing the healthcare sector, creating pharmaceutical innovations and ensuring drug safety. Healthcare professionals are given the latest information about pharmaceutical treatments, and they, in turn, can serve as expert advisers to pharmaceutical companies. We cooperate for the benefit of patients. The information about cooperation between pharmaceutical companies and healthcare professionals is available to everyone.
Download the attached files for details:
Disclosure Estonia 2021 (PDF) Methodology note Estonia 2021 (PDF)
Disclosure Latvia 2021 (PDF) Sponsorship report 2021
Disclosure Lithuania 2021 (PDF) Sponsorship report 2021
Disclosure Estonia 2020 (PDF) Methodology note Estonia 2020 (PDF)
Disclosure Latvia 2020 (PDF) Methodology note Latvia 2020 (PDF)
Disclosure Lithuania 2020 (PDF) Methodology note Lithuania 2020 (PDF)
Disclosure Estonia 2019 (PDF) Methodology note Estonia 2019 (PDF)
Disclosure Latvia 2019 (PDF) Methodology note Latvia 2019 (PDF)
Disclosure Lithuania 2019 (PDF)
Want to know more?
Biocodex teams share common values and make them live as driving forces. They belong to all teams as they were created by them. They are rooted in Biocodex DNA. Here are Biocodex four values: we dare to innovate, we play collectively, we shape fair relations and we care for our ecosystem.
Biocodex operates in more than 120 countries where we anchor our operations through robust partnerships and by creating our own operational footprint through 20 subsidiaries around the world. Biocodex’s 1,530 employees are committed to serving millions of patients around the world. We apply our expertise to a wide range of products to meet patient needs, focusing on three pillars: the Microbiota Mission, orphan drugs and women’s health.